The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Buprenorphine for the Management of 7-Hydroxymitragynine (7-OH) Use: A Retrospective Case Series.
Abstract
Kratom (Mitragyna speciosa) and its active alkaloids mitragynine and 7-hydroxymitragynine (7-OH) demonstrate mu-opioid receptor activity. Purified 7-OH products produce disproportionately strong opioid effects compared with natural kratom, increasing the risk of dependence. Buprenorphine has been used to manage 7-OH withdrawal. This retrospective chart review describes buprenorphine initiation among patients with problematic 7-OH use. Successful initiation was associated with symptom improvement, supporting clinical approaches for this emerging substance use disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cinosi, E., Martinotti, G., Simonato, P., Singh, D., Demetrovics, Z., Roman-Urrestarazu, A., Bersani, F. S., Vicknasingam, B., Piazzon, G., Li, J.-H., et al. (2015) · BioMed Research International · doi:10.1155/2015/968786 · Cited by 234
Matsumoto, K., Horie, S., Ishikawa, H., Takayama, H., Aimi, N., Ponglux, D., & Watanabe, K. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.054 · Cited by 228
Henningfield, J. E., Fant, R. V., & Wang, D. W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4813-4 · Cited by 151
Todd, D. A., Kellogg, J. J., Wallace, E. D., Khin, M., Flores‐Bocanegra, L., Tanna, R. S., McIntosh, S., Raja, H. A., Graf, T. N., Hemby, S. E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76119-w · Cited by 134
Matsumoto, K., Hatori, Y., Murayama, T., Tashima, K., Wongseripipatana, S., Misawa, K., Kitajima, M., Takayama, H., & Horie, S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.013 · Cited by 107
Kratom Use and Toxicities in the United States
Eggleston, W. D., Stoppacher, R., Suen, K. P., Marraffa, J. M., & Nelson, L. S. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2280 · Cited by 106
A Drug Toxicity Death Involving Propylhexedrine and Mitragynine*
Holler, J. M., Vorce, S. P., McDonough-Bender, P. C., et al. (2011) · Journal of Analytical Toxicology · doi:10.1093/anatox/35.1.54 · Cited by 104
D’Onofrio, G., Hawk, K. F., Perrone, J., WALSH, S. L., Lofwall, M. R., Fiellin, D. A., & Herring, A. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.6108 · Cited by 77
McNeely, J., Wang, S. S., Abadi, Y. R., Barron, C. T., Billings, J., Tarpey, T., Fernando, J., Appleton, N., Fawole, A., Mazumdar, M., et al. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.3422 · Cited by 74
Weiss, S. T., & Douglas, H. E. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000721 · Cited by 53
Cited by
Moss, M. J., Altholz, J., Babu, K. M., Perrone, J., & Stolbach, A. I. (2026) · Journal of Medical Toxicology · doi:10.1007/s13181-026-01154-4
Metadata
- Authors
- Fenske, E., Williams, B., Hallock-Koppelman, L., & Buchheit, B. M.
- Affiliations
- Oregon Health & Science University (US)
- Venue
- Journal of addiction medicine
- Published
- 2026-06-01
- ISSN
- 1932-0620 (ISSN-L)
- 1935-3227
- OpenAlex
- W7163082224
- Cited by
- 2
- References
- 19
- Citations by year
- 2026: 2
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Addiction Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- buprenorphine, 7-hydroxymitragynine, Mitragyna speciosa, opioid withdrawal, substance use disorders, initiation timing, dosing regimen, mu-opioid receptor agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Buprenorphine for the Management of 7-Hydroxymitragynine (7-OH) Use: A Retrospective Case Series. https://app.cochat.ai/papers/10.1097/adm.0000000000001723
- The paper
- Fenske, E., Williams, B., Hallock-Koppelman, L., & Buchheit, B. M. (2026). Buprenorphine for the Management of 7-Hydroxymitragynine (7-OH) Use: A Retrospective Case Series. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001723
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.